Vivek Naranbhai

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 19

Top Topics

Natural Killer Cells

Systematic Review

Respiratory Syndrome Coronavirus

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

medRxiv : the preprint server for health sciences

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Fergus W Hamilton, Haiko Schurz, Tom A Yates, James J Gilchrist, Marlo Möller, Vivek Naranbhai, Peter Ghazal, Nicholas J Timpson, null null, Tom Parks, Gabriele Pollara
Altered IL-6 signalling and risk of tuberculosis disease: a meta-analysis and Mendelian randomisation study. medRxiv : the preprint server for health sciences (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Fergus W Hamilton, Haiko Schurz, Tom A Yates, James J Gilchrist, Marlo Möller, Vivek Naranbhai, Peter Ghazal, Nicholas J Timpson, null null, Tom Parks, Gabriele Pollara
Altered IL-6 signalling and risk of tuberculosis disease: a meta-analysis and Mendelian randomisation study. medRxiv : the preprint server for health sciences (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Fergus W Hamilton, Haiko Schurz, Tom A Yates, James J Gilchrist, Marlo Möller, Vivek Naranbhai, Peter Ghazal, Nicholas J Timpson, null null, Tom Parks, Gabriele Pollara
Altered IL-6 signalling and risk of tuberculosis disease: a meta-analysis and Mendelian randomisation study. medRxiv : the preprint server for health sciences (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L Munn, Rakesh K Jain
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Reza Zonozi, Lucy C Walters, Aaron Shulkin, Vivek Naranbhai, Pravarut Nithagon, Gabriel Sauvage, Clarety Kaeske, Katherine Cosgrove, Anusha Nathan, Rhoda Tano-Menka, Alton C Gayton, Matthew A Getz, Fernando Senjobe, Daniel P Worrall, A John Iafrate, Caroline Fromson, Sydney B Montesi, Deepak A Rao, Jeffrey A Sparks, Zachary Scott Wallace, Jocelyn R Farmer, Bruce D Walker, Richelle C Charles, Karen Laliberte, John L Niles, Gaurav D Gaiha
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19. Science translational medicine 15 (724) (2023)
Victoria Walker-Sperling, Jean C Digitale, Mathias Viard, Maureen P Martin, Arman Bashirova, Yuko Yuki, Veron Ramsuran, Smita Kulkarni, Vivek Naranbhai, Hongchuan Li, Stephen K Anderson, Lauren Yum, Robert Clifford, Hannah Kibuuka, Julie Ake, Rasmi Thomas, Sarah L Rowland-Jones, John Rek, Emmanuel Arinaitwe, Moses R Kamya, Isabel Rodriguez-Barraquer, Margaret E Feeney, Mary N Carrington
Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 119 (29) (2022)
Vivek Naranbhai, Anusha Nathan, Clarety Kaseke, Cristhian Berrios, Ashok Khatri, Shawn Choi, Matthew A Getz, Rhoda Tano-Menka, Onosereme Ofoman, Alton Gayton, Fernando Senjobe, Kerri J St Denis, Evan C Lam, Wilfredo F Garcia-Beltran, Alejandro B Balazs, Bruce D Walker, A John Iafrate, Gaurav D Gaiha
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. medRxiv : the preprint server for health sciences (2022)
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, Cristhian Berrios Mairena, Julia C Thierauf, Grace Kirkpatrick, Maristela L Onozato, Ju Cheng, Kerri J St Denis, Evan C Lam, Clarety Kaseke, Rhoda Tano-Menka, Diane Yang, Maia Pavlovic, Wendy Yang, Alexander Kui, Tyler E Miller, Michael G Astudillo, Jennifer E Cahill, Anand S Dighe, David J Gregory, Mark C Poznansky, Gaurav D Gaiha, Alejandro B Balazs, A John Iafrate
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines. medRxiv : the preprint server for health sciences (2021)
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, Cristhian Berrios Mairena, Julia C Thierauf, Grace Kirkpatrick, Maristela L Onozato, Ju Cheng, Kerri J St Denis, Evan C Lam, Clarety Kaseke, Rhoda Tano-Menka, Diane Yang, Maia Pavlovic, Wendy Yang, Alexander Kui, Tyler E Miller, Michael G Astudillo, Jennifer E Cahill, Anand S Dighe, David J Gregory, Mark C Poznansky, Gaurav D Gaiha, Alejandro B Balazs, A John Iafrate
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines. The Journal of infectious diseases (2021)
Vivek Naranbhai, Claire A Pernat, Alexander Gavralidis, Kerri J St Denis, Evan C Lam, Laura M Spring, Steven Jay Isakoff, Jocelyn R Farmer, Leyre Zubiri, Gabriela S Hobbs, Joan How, Andrew M Brunner, Amir T Fathi, Jennifer L Peterson, Mustafa Sakhi, Grace Hambelton, Elyssa N Denault, Lindsey J Mortensen, Lailoo A Perriello, Marissa N Bruno, Brittany Y Bertaux, Aleigha R Lawless, Monica A Jackson, Elizabeth Niehoff, Caroline Barabell, Christian N Nambu, Erika Nakajima, Trenton Reinicke, Cynthia Bowes, Cristhian J Berrios-Mairena, Onosereme Ofoman, Grace E Kirkpatrick, Julia C Thierauf, Kerry Lynn Reynolds, Henning Willers, Wilfredo-Garcia Beltran, Anand S Dighe, Rebecca R Saff, Kimberly G Blumenthal, Ryan J Sullivan, Yi-Bin Chen, Arthur Y Kim, Aditya Bardia, Alejandro B Balazs, A John Iafrate, Justin F Gainor
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Arman A Bashirova, Mathias Viard, Vivek Naranbhai, Alba Grifoni, Wilfredo Garcia-Beltran, Marjan Akdag, Yuko Yuki, Xiaojiang Gao, Colm O'hUigin, Malini Raghavan, Steven Wolinsky, Jay H Bream, Priya Duggal, Jeremy Martinson, Nelson L Michael, Gregory D Kirk, Susan P Buchbinder, David Haas, James J Goedert, Steven G Deeks, Jacques Fellay, Bruce D Walker, Philip Goulder, Peter Cresswell, Tim Elliott, Alessandro Sette, Jonathan Carlson, Mary N Carrington
HLA tapasin independence: broader peptide repertoire and HIV control. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
James J Gilchrist, Anna Rautanen, Benjamin P Fairfax, Tara C Mills, Vivek Naranbhai, Holly Trochet, Matti Pirinen, Esther Muthumbi, Salim Mwarumba, Patricia Njuguna, Neema Mturi, Chisomo L Msefula, Esther N Gondwe, Jenny M MacLennan, Stephen J Chapman, Malcolm E Molyneux, Julian C Knight, Chris C A Spencer, Thomas N Williams, Calman A MacLennan, J Anthony G Scott, Adrian V S Hill
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4. Nature communications 9 (1) (2018)
Veron Ramsuran, Vivek Naranbhai, Amir Horowitz, Ying Qi, Maureen P Martin, Yuko Yuki, Xiaojiang Gao, Victoria E K Walker-Sperling, Gregory Q Del Prete, Douglas K Schneider, Jeffrey D Lifson, Jacques Fellay, Steven G Deeks, Jeffrey N Martin, James J Goedert, Steven M Wolinsky, Nelson L Michael, Gregory D Kirk, Susan Buchbinder, David W Haas, Thumbi Ndung'u, Philip J R Goulder, Peter Parham, Bruce D Walker, Jonathan M Carlson, Mary N Carrington
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science (New York, N.Y.) 359 (6371) (2018)
Vivek Naranbhai, Benjamin P Fairfax, Seiko Makino, Peter Humburg, Daniel Wong, Esther Ng, Adrian V S Hill, Julian C Knight
Genomic modulators of gene expression in human neutrophils. Nature communications 6 (2015)